Business Development We have signed an evaluation agreement with Thyrocare, a large Indian network of diagnostic labs. They will evaluate our tuberculosis diagnostic in the coming year.Clemedi conducted interviews with key-opinion leaders to validate the product-market fit of current and future products. Also, Niko attended three (virtual) conferences, South Summit, Wolf Summit and DxPx Europe.…
read more
Business Development We have been selected by Swissnex to join the India Market Entry camp. Our team will travel to India to strengthen its market entry strategy for this important market.We are also negotiating OEM agreements with our suppliers, enabling us to sell a Clemedi branded box with all reagents. You can see our current…
read more
Business Development We finalised the license agreement with the University of Zurich. This license gives us the exclusive right to use on the patent application necessary to commercialize the Tuberculini product. We have made progress with potential collaboration partners in India, who are interested in our technology. Company Development In our last General Assembly we…
read more